Hyperglycaemia induced by isoniazid preventive therapy

Hyperglycaemia induced by isoniazid preventive therapy

We report the case of a HIV-positive patient with type 2 diabetes mellitus who presented with uncontrolled blood sugars after the initiation of prophylactic isoniazid (INH) therapy. INH is widely used for prophylaxis and treatment of tuberculosis (TB) around the world and INH-induced hyperglycaemia...

Full description

Bibliographic Details
Main Authors:	Roshni Jhan Ganguly, Rahul R Abraham, Ramakrishna Prasad, Badakere C Rao
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2018-01-01
Series:	Journal of Family Medicine and Primary Care
Subjects:	Hyperglycaemia isoniazid isoniazid prophylaxis therapy
Online Access:	http://www.jfmpc.com/article.asp?issn=2249-4863;year=2018;volume=7;issue=5;spage=1123;epage=1125;aulast=Ganguly

Similar Items

Formulation of dispersible isoniazid/pyridoxine fixed-dose combination tablets for isoniazid preventive therapy in pediatrics
by: M. W. Mwangi, et al.
Published: (2020-01-01)

Isoniazid- and ethambutol-induced psychosis
by: Prasad R, et al.
Published: (2008-01-01)

Comparative analysis of the effectiveness of tuberculosis prophylaxis in patients with HIV/AIDS treated with isoniazid
by: Konrad Juszkiewicz, et al.
Published: (2019-09-01)

Status of contact screening and isoniazid preventive therapy for children under age six in Puducherry district, under the Revised National Tuberculosis Control Programme: An operational research
by: Ariarathinam Newtonraj, et al.
Published: (2020-01-01)

Isoniazid-induced thrombocytopenia in a patient with ocular tuberculosis
by: Preeti Gupta, et al.
Published: (2019-01-01)

Pharmacoprophylactic equivalence of rifapentine compared with isoniazid: an appraisal for HIV-infected population
by: Beuy Joob, et al.
Published: (2021-01-01)

Isoniazid-induced alopecia
by: K B Gupta, et al.
Published: (2011-01-01)

ISONIAZID - MONORESISTANT TUBERCULOSIS IN BULGARIA
by: Stanislava Yordanova, et al.
Published: (2020-05-01)

Isoniazid-induced gynaecomastia: report of a paediatric case and review of literature
by: Sarah Wing Yiu Poon, et al.
Published: (2020-10-01)

Coverage of isoniazid preventive therapy among people living with HIV; A retrospective cohort study in Tanzania (2012-2016)
by: Werner Maokola, et al.
Published: (2021-02-01)

Isoniazid-induced acute pancreatitis in a child with tuberculous meningitis
by: Himali Meshram, et al.
Published: (2018-01-01)

The use of isoniazid syrup for the prevention of tuberculosis in children.
by: Liliya Todoriko, et al.
Published: (2019-09-01)

Factors associated with isoniazid preventive treatment interruption and completion among PLHIV in Gombe Hospital, Uganda, 2017–2019
by: Emmanuel Ssendikwanawa, et al.
Published: (2023-05-01)

Severe isoniazid related sideroblastic anemia
by: Rein Jan Piso, et al.
Published: (2011-01-01)

Treatment of Isoniazid-Resistant Pulmonary Tuberculosis
by: Byung Woo Jhun, M.D., et al.
Published: (2020-01-01)

The Effects of Isoniazid on the Acquisition and Expression of Morphine-Induced Conditioned Place Preference in Mice
by: Amir Barzegari, et al.
Published: (2020-01-01)

A validated liquid chromatography-tandem mass spectrometry assay for the analysis of isoniazid and its metabolite acetyl-isoniazid in urine
by: Sydwell Poulo Maputla, et al.
Published: (2024-04-01)

Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania
by: Olivia F. Hunter, et al.
Published: (2020-10-01)

Isoniazid‐induced pellagra in a patient with Crohn's disease
by: Hela Kchir, et al.
Published: (2020-05-01)

Complication of Mycobacterium tuberculosis treatment: Isoniazid-induced pneumonitis
by: Brian Cody Adkinson, et al.
Published: (2020-11-01)

Perceived barriers to the implementation of Isoniazid preventive therapy for people living with HIV in resource constrained settings: a qualitative study
by: Mesele Mindachew, et al.
Published: (2014-01-01)

Knowledge and Attitudes of Indonesian General Practitioners Towards the Isoniazid Preventive Therapy Program in Indonesia
by: Wira Winardi, et al.
Published: (2022-09-01)

Protective effects of salep against isoniazid liver toxicity in wistar rats
by: Hossein Kargar Jahromi, et al.
Published: (2018-01-01)

Improving coverage and completion rate of isoniazid preventive therapy among eligible HIV patients using quality improvement approaches: a case study of State Hospital, Ijebu Ode, Ogun State, Nigeria
by: Olabanjo Okunlola Ogunsola, et al.
Published: (2019-12-01)

Influence of isoniazid on T lymphocytes, cytokines, and macrophages in rats
by: Bianchuan Cao, et al.
Published: (2020-09-01)

Synthesis and antitubercular activity of isoniazid condensed with carbohydrate derivatives
by: Sílvia H. Cardoso, et al.
Published: (2009-01-01)

Phenotypic low-level isoniazid resistance as a marker to predict ethionamide resistance in Mycobacterium tuberculosis
by: Salima Qamar, et al.
Published: (2017-01-01)

Choice of optimal conditions of Isoniazid and Thiotriazolin artificial mixture analysis by high-performance liquid chromatography method
by: L. I. Kucherenko, et al.
Published: (2014-04-01)

Development and Evaluation of Isoniazid Loaded Silk Fibroin Microsphere
by: Narinder Singh, et al.

Molecular characterization of Mycobacterium tuberculosis strains resistant to isoniazid
by: Salma Smaoui, et al.
Published: (2016-01-01)

Selenium as a therapeutic adjuvant for isoniazid/rifampicin-induced hepatotoxicity
by: Elias Adikwu, et al.
Published: (2020-01-01)

Chemoprophylaxis for the prevention of tuberculosis in kidney transplant recipients: A systematic review and meta-analysis
by: Zhihui Yuan, et al.
Published: (2023-03-01)

Assessment of contextual factors shaping delivery and uptake of isoniazid preventive therapy among people living with HIV in Dar es salaam, Tanzania
by: Renatus Fabiano Nyarubamba, et al.
Published: (2022-11-01)

Cutaneous ichthyosis secondary to isoniazid
by: Hatim Kouismi, et al.
Published: (2013-04-01)

Enhancing antimycobacterial activity of isoniazid and rifampicin incorporated norbornene nanoparticles
by: Kalaiselvi Kumarasingam, et al.
Published: (2018-01-01)

Synthesis and Characterization of Chitosan- Alginate for Controlled Release of Isoniazid Drug
by: Sari Edi Cahyaningrum, et al.
Published: (2015-03-01)

Isoniazid Preventive Therapy Uptake and Its Effect on Tuberculosis Incidence Among People Living with HIV in Illubabor and Buno Bedelle Zones, South-West Ethiopia, 2022: A Retrospective Cohort Study
by: Mulatu G, et al.
Published: (2023-11-01)

Isoniazid-induced flu-like syndrome: A rare side effect
by: Sudipta Pandit, et al.
Published: (2013-01-01)

Knowledge, attitudes and practices of doctors regarding isoniazid preventive therapy in HIV/AIDS patients at Odi District Hospital, Gauteng province, South Africa
by: A. T. Abdulrazaak, et al.
Published: (2018-12-01)

Barriers and facilitators for isoniazid preventive therapy (IPT) administration in children under 5 years of age in the Dominican Republic
by: Grey Idalia Benoit Vásquez, et al.
Published: (2022-04-01)